These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 16787750)

  • 1. Valproic acid induced encephalopathy--19 new cases in Germany from 1994 to 2003--a side effect associated to VPA-therapy not only in young children.
    Gerstner T; Buesing D; Longin E; Bendl C; Wenzel D; Scheid B; Goetze G; Macke A; Lippert G; Klostermann W; Mayer G; Augspach-Hofmann R; Fitzek S; Haensch CA; Reuland M; Koenig SA
    Seizure; 2006 Sep; 15(6):443-8. PubMed ID: 16787750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Valproate-induced hyperammonemic encephalopathy: an update on risk factors, clinical correlates and management.
    Chopra A; Kolla BP; Mansukhani MP; Netzel P; Frye MA
    Gen Hosp Psychiatry; 2012; 34(3):290-8. PubMed ID: 22305367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topiramate increases the risk of valproic acid-induced encephalopathy.
    Noh Y; Kim DW; Chu K; Lee ST; Jung KH; Moon HJ; Lee SK
    Epilepsia; 2013 Jan; 54(1):e1-4. PubMed ID: 22691153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valproate (VPA)-associated hyperammonemic encephalopathy independent of elevated serum VPA levels: 21 cases in China from May 2000 to May 2012.
    Cheng M; Tang X; Wen S; Yue J; Wang H
    Compr Psychiatry; 2013 Jul; 54(5):562-7. PubMed ID: 23246073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valproate induced non hepatic hyperammonaemic encephalopathy (VNHE)--a study from tertiary care referral university hospital, north India.
    Mehndiratta MM; Mehndiratta P; Phul P; Garg S
    J Pak Med Assoc; 2008 Nov; 58(11):627-31. PubMed ID: 19024136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Valproate-induced hyperammonemic encephalopathy in a patient with Sjögren's syndrome].
    Nakazato Y; Ando S; Yamamoto T; Tamura N; Shimazu K
    Rinsho Shinkeigaku; 2004 Oct; 44(10):682-5. PubMed ID: 15568484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two cases of valproate-induced hyperammonemic encephalopathy without hepatic failure.
    Panda S; Radhakrishnan K
    J Assoc Physicians India; 2004 Sep; 52():746-8. PubMed ID: 15839456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of hyperammonaemic encephalopathy due to valproic acid.
    Prins MC; van Meijel JJ
    Neth J Med; 2011 Sep; 69(9):389-91. PubMed ID: 21978982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valproate-induced hyperammonemia in juvenile ceroid lipofuscinosis (Batten disease).
    Larsen EP; Ostergaard JR
    Seizure; 2014 Jun; 23(6):429-34. PubMed ID: 24647346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valproic acid-induced encephalopathy in very long course treated patients.
    Rousseau MC; Montana M; Villano P; Catala A; Blaya J; Valkov M; Allouard Y; Bugni E
    Brain Inj; 2009 Nov; 23(12):981-4. PubMed ID: 19831495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valproate-associated hyperammonemic encephalopathy.
    Wadzinski J; Franks R; Roane D; Bayard M
    J Am Board Fam Med; 2007; 20(5):499-502. PubMed ID: 17823470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Valproic acid-induced hyperammonemic encephalopathy in a patient receiving valproic acid monotherapy].
    Yamada H; Shishido T; Mukai T; Araki M; Naka H; Tokinobu H
    Rinsho Shinkeigaku; 2019 May; 59(5):258-263. PubMed ID: 31061301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Valproate can induce reversible encephalopathy].
    Prakash S; Harbo T; Christensen J
    Ugeskr Laeger; 2014 Nov; 176(45):. PubMed ID: 25394838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carnitine in the treatment of valproic acid-induced toxicity.
    Lheureux PE; Hantson P
    Clin Toxicol (Phila); 2009 Feb; 47(2):101-11. PubMed ID: 19280426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valproate induced hyperammonemic encephalopathy successfully treated with levocarnitine.
    Rigamonti A; Lauria G; Grimod G; Bianchi G; Salmaggi A
    J Clin Neurosci; 2014 Apr; 21(4):690-1. PubMed ID: 24119342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The decreased level of plasma carnitine in patients with epilepsy].
    Belousova ED
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(6):106-110. PubMed ID: 28745680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lamotrigine might potentiate valproic acid-induced hyperammonemic encephalopathy.
    Fan CC; Huang MC; Liu HC
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Oct; 32(7):1747-8. PubMed ID: 18602440
    [No Abstract]   [Full Text] [Related]  

  • 18. Valproate-induced hyperammonemic encephalopathy.
    Verrotti A; Trotta D; Morgese G; Chiarelli F
    Metab Brain Dis; 2002 Dec; 17(4):367-73. PubMed ID: 12602513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Valproate can induce reversible encephalopathy].
    Prakash S; Harbo T; Christensen J
    Ugeskr Laeger; 2015 May; 177(20):945-6. PubMed ID: 26535436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valproate-induced hyperammonemic encephalopathy: a brief review.
    Lewis C; Deshpande A; Tesar GE; Dale R
    Curr Med Res Opin; 2012 Jun; 28(6):1039-42. PubMed ID: 22587482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.